Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Effects of Ivabradine and Ranolazine in Patients With Microvascular Angina Pectoris

(2013) Angelo Villano et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials

(2013) Kim Fox et al.   EUROPEAN HEART JOURNAL

Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders

(2013) Marcel den Hoed et al.   NATURE GENETICS

Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients

(2012) Roberto Nerla et al.   HEART

Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study

(2012) Alberto Dominguez-Rodriguez et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Clinical Efficacy of Ivabradine in Patients With Inappropriate Sinus Tachycardia

(2012) Riccardo Cappato et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

(2012) Adam P. Gregory et al.   NATURE

Meta-analysis identifies six new susceptibility loci for atrial fibrillation

(2012) Patrick T Ellinor et al.   NATURE GENETICS

PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis

(2011) Ana Chinchilla et al.   Circulation-Cardiovascular Genetics

Effects of Ivabradine on the Pulmonary Vein Electrical Activity and Modulation of Pacemaker Currents and Calcium Homeostasis

(2011) KAZUYOSHI SUENARI et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

(2009) J.-C. Tardif et al.   EUROPEAN HEART JOURNAL

Comparison of Ivabradine Versus Metoprolol in Early Phases of Reperfused Anterior Myocardial Infarction With Impaired Left Ventricular Function: Preliminary Findings

(2009) Sergio Fasullo et al.   JOURNAL OF CARDIAC FAILURE

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET